Skip to main content
Pulike Biological Engineering,Inc. logo

Pulike Biological Engineering,Inc. — Investor Relations & Filings

Ticker · 603566 ISIN · CNE1000025N0 Shanghai Stock Exchange Manufacturing
Filings indexed 1,080 across all filing types
Latest filing 2016-04-08 Board/Management Inform…
Country CN China
Listing Shanghai Stock Exchange 603566

About Pulike Biological Engineering,Inc.

http://en.pulike.com.cn/

Pulike Biological Engineering, Inc. specializes in the research, development, and production of veterinary biological products and pharmaceutical preparations. The company focuses on animal disease prevention through the manufacture of high-end vaccines, diagnostic reagents, and veterinary medicines. Its product range primarily serves the swine and poultry sectors, featuring advanced biologicals such as genetically engineered vaccines and synthetic peptide products. Pulike maintains a strong emphasis on technological innovation, utilizing national-level research platforms to develop solutions for complex animal health challenges. The company’s core activities encompass the entire value chain from basic biotechnology research to the commercialization of veterinary health solutions, aiming to improve livestock productivity and biosecurity.

Recent filings

Filing Released Lang Actions
关于修订公司章程的公告
Board/Management Information Classification · 95% confidence The document is an announcement from the board of directors of 普莱柯生物工程股份有限公司 regarding amendments to the company's articles of association (公司章程). It details specific changes to the company's governance structure, including the composition and powers of the board and chairman. The document is a formal public announcement of these governance changes and does not contain financial statements, audit information, or detailed financial data. It is not a full annual report, interim report, or earnings release. It is also not a proxy solicitation or voting results announcement. The content fits best under Board/Management Information (MANG) as it relates to changes in the company's board structure and governance roles. The document length is short and focused on governance changes, supporting this classification with high confidence.
2016-04-08 Chinese
2015年年度报告摘要
Annual Report Classification · 95% confidence The document is titled as a 2015 annual report summary for 普莱柯生物工程股份有限公司, containing detailed financial data for the year 2015, including total assets, revenue, net profit, quarterly financial indicators, shareholder information, management discussion and analysis, and notes on accounting policies. It includes comprehensive business descriptions, financial performance, and management commentary typical of an annual report. The document length is 8452 characters, which is sufficient to contain substantive financial data and analysis, not just an announcement or summary. There is also mention of an audit report with an unqualified opinion, but the document itself is not a standalone audit report. Therefore, this document fits the definition of an Annual Report (10-K). FY 2015
2016-04-08 Chinese
2015年度监事会工作报告
Audit Report / Information Classification · 90% confidence The document is titled '2015年度监事会工作报告' which translates to '2015 Supervisory Board Work Report' of 普莱柯生物工程股份有限公司. It details the supervisory board's activities, including meetings held, review of financial reports, internal controls, and use of raised funds. It is a report on the supervisory board's work and oversight activities rather than a full annual report or audit report. The document length is 1797 characters, which is relatively short and focused on supervisory board work rather than comprehensive financial statements. This fits best with the category of Audit Report / Information (AR), as it includes audit-related supervisory activities and internal control reviews but is not a full annual report (10-K) or management report (MDA). FY 2015
2016-04-08 Chinese
关于对部分暂时闲置募集资金及公司自有资金进行现金管理的公告
Capital/Financing Update Classification · 95% confidence The document is a company announcement regarding the management of temporarily idle raised funds and the company's own funds through cash management. It details the approval process, the amount of funds involved, the purpose, risk control measures, and opinions from independent directors, the supervisory board, and the sponsor institution. The document does not contain financial statements or detailed financial results but is an announcement about the company's cash management activities related to raised funds. It is not an annual or interim report, audit report, earnings release, or any other detailed financial report. The document is relatively short (3085 characters) and serves as a formal disclosure of a financing-related activity. Therefore, it fits best under Capital/Financing Update (CAP).
2016-04-08 Chinese
审计委员会2015年度履职情况报告
Audit Report / Information Classification · 95% confidence The document is titled as an "Audit Committee 2015 Annual Performance Report" from the company's Audit Committee. It details the committee's activities during the 2015 fiscal year, including evaluation of the external auditor's independence, review of financial reports from 2012 to 2015 interim periods, supervision of internal audit work, and internal control improvements. The document is a report on the audit committee's work and oversight rather than a full audit report or financial statements. It does not contain standalone audit opinions or detailed accounting principles but rather a summary of audit committee activities and evaluations. This fits the definition of an Audit Report / Information (AR) filing, which includes standalone audit reports and related information excluding full annual reports. The document length is 2634 characters, which is consistent with a committee report rather than a full annual report or interim report. Therefore, the appropriate classification is AR with high confidence. FY 2015
2016-04-08 Chinese
2015年年度报告
Annual Report Classification · 100% confidence The document is titled '2015 年年度报告' which translates to '2015 Annual Report'. It contains detailed sections typical of an annual report such as company overview, financial data, management discussion and analysis, business overview, governance, and financial statements. The document includes audited financial data, management's discussion and analysis, risk disclosures, and detailed company information. It also references the audit report by an accounting firm but is not just the audit report itself. The length of the document (15,000 characters) and the detailed content confirm it is the full annual report rather than an announcement or summary. Therefore, the document fits the definition of an Annual Report (10-K). FY 2015
2016-04-08 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.